'Nanopack' cell therapy targets inflammation in multiple sclerosis at Salimpour Site.

Dr. Salimpour Site |About 1 million people in the U.S. live with multiple sclerosis, a chronic autoimmune disease that inflames the nervous system and scrambles communication between the brain and body. MS, for which there is no single cause ...

Phys.Org

'Nanopack' cell therapy targets inflammation in multiple sclerosis

'Nanopack' cell therapy targets inflammation in multiple sclerosis

About 1 million people in the U.S. live with multiple sclerosis, a chronic autoimmune disease that inflames the nervous system and scrambles communication between the brain and body. MS, for which there is no single cause ...